Somatostatin analogues in the treatment of the carcinoid syndrome.
Somatostatin analogs have been found useful in a variety of endocrine-related diseases. In particular, patients with malignant carcinoid syndrome benefit from their administration. A review of published data and a rationale for their use is hereby presented.
Deghenghi
R
R
Debiopharm S.A., Lausanne, Switzerland.
D002276:Carcinoid Tumor / Q000188:drug therapy*; D006801:Humans; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D013004:Somatostatin